Page last updated: 2024-10-24

candesartan and Embolism

candesartan has been researched along with Embolism in 1 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Embolism: Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishrat, T1
Pillai, B1
Ergul, A1
Hafez, S1
Fagan, SC1

Other Studies

1 other study available for candesartan and Embolism

ArticleYear
Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.
    Neurochemical research, 2013, Volume: 38, Issue:12

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blotting, West

2013